James Binch #Sold 4,650 #Shares of Exactech, Inc. (EXAC); #Marshfield #Associates Lowered By $828,065 Its #Expeditors International Of #Washington (EXPD) #Holding

Marshfield Associates decreased Expeditors International Of Washington (EXPD) stake by 1.17% reported in 2017Q3 SEC filing. Marshfield Associates sold 14,035 shares as Expeditors International Of Washington (EXPD)’s stock declined 6.64%. The Marshfield Associates holds 1.18 million shares with $70.71 million value, down from 1.20 million last quarter. Expeditors International Of Washington now has $11.39B valuation. The stock decreased 0.11% or $0.07 during the last trading session, reaching $64.12. About 2.95M shares traded or 161.32% up from the average. Expeditors International of Washington, Inc. (NASDAQ:EXPD) has risen 10.45% since February 17, 2017 and is uptrending. It has underperformed by 6.25% the S&P500.

The Exactech Inc’s director, James Binch, the well informed man made a sale of – 4,650 Exactech Inc’s shares, based on the average share price of $49.3 for each one share. This sale of shares has a value of precisely $229,013 U.S. Dollars. For more details of this deal please access the SEC’s filing free at your disposal here.

Investors sentiment decreased to 1.04 in Q3 2017. Its down 0.02, from 1.06 in 2017Q2. It dropped, as 29 investors sold EXPD shares while 155 reduced holdings. 43 funds opened positions while 149 raised stakes. 160.89 million shares or 0.51% less from 161.72 million shares in 2017Q2 were reported. Evercore Wealth Ltd accumulated 0.01% or 4,955 shares. Cwm has invested 1.58% in Expeditors International of Washington, Inc. (NASDAQ:EXPD). Aqr Cap Management Limited Com holds 0.04% of its portfolio in Expeditors International of Washington, Inc. (NASDAQ:EXPD) for 609,851 shares. Raymond James & owns 158,376 shares. World Asset owns 17,711 shares for 0.04% of their portfolio. Anchor Lc holds 0.57% of its portfolio in Expeditors International of Washington, Inc. (NASDAQ:EXPD) for 262,674 shares. Retirement Systems Of Alabama reported 0.03% in Expeditors International of Washington, Inc. (NASDAQ:EXPD). Middleton & Ma has invested 0.04% of its portfolio in Expeditors International of Washington, Inc. (NASDAQ:EXPD). State Of Tennessee Treasury Department has 49,023 shares. Ameriprise Financial holds 1.48 million shares. Natl Bank Of Montreal Can reported 0.01% of its portfolio in Expeditors International of Washington, Inc. (NASDAQ:EXPD). Lombard Odier Asset Management (Switzerland) Sa owns 34,547 shares for 0.2% of their portfolio. Jane Street Gru Lc holds 20,756 shares. First Manhattan, a New York-based fund reported 460 shares. Moreover, Renaissance Limited Company has 0.01% invested in Expeditors International of Washington, Inc. (NASDAQ:EXPD) for 146,500 shares.

Analysts await Expeditors International of Washington, Inc. (NASDAQ:EXPD) to report earnings on February, 20. They expect $0.64 EPS, up 4.92% or $0.03 from last year’s $0.61 per share. EXPD’s profit will be $113.73M for 25.05 P/E if the $0.64 EPS becomes a reality. After $0.66 actual EPS reported by Expeditors International of Washington, Inc. for the previous quarter, Wall Street now forecasts -3.03% negative EPS growth.

Among 15 analysts covering Expeditors International of Washington (NASDAQ:EXPD), 3 have Buy rating, 2 Sell and 10 Hold. Therefore 20% are positive. Expeditors International of Washington had 42 analyst reports since August 11, 2015 according to SRatingsIntel. The firm has “Hold” rating by Stifel Nicolaus given on Tuesday, August 25. The stock of Expeditors International of Washington, Inc. (NASDAQ:EXPD) has “Positive” rating given on Tuesday, August 11 by Susquehanna. The company was maintained on Monday, October 5 by Barclays Capital. On Tuesday, September 22 the stock rating was maintained by S&P Research with “Buy”. The firm earned “Equal-Weight” rating on Monday, April 4 by Stephens. The firm has “Overweight” rating by Barclays Capital given on Monday, October 2. The firm has “Neutral” rating by Macquarie Research given on Wednesday, November 4. On Monday, July 17 the stock rating was maintained by Cowen & Co with “Hold”. The firm earned “Hold” rating on Thursday, August 10 by Stifel Nicolaus. On Friday, March 18 the stock rating was initiated by Cowen & Co with “Market Perform”.

Exactech, Inc. develops, manufactures, markets, distributes, and sells orthopedic implant devices, related surgical instrumentation, and biologic services. The company has market cap of $710.38 million. It offers extremities products comprising Equinoxe, a platform shoulder system for the treatment of degenerative disease and trauma; and knee system that provides solutions for partial, primary, and revision total knee arthroplasty. It has a 1894.23 P/E ratio. The firm also provides hip solutions that address hip arthroplasty, reconstruction, and fractures, as well as primary hip surgeries.

Among 4 analysts covering Exactech (NASDAQ:EXAC), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Exactech has $49.0 highest and $20 lowest target. $34.50’s average target is -29.95% below currents $49.25 stock price. Exactech had 9 analyst reports since August 21, 2015 according to SRatingsIntel. Gabelli downgraded the shares of EXAC in report on Tuesday, October 24 to “Hold” rating. As per Friday, October 13, the company rating was maintained by Robert W. Baird. Robert W. Baird downgraded it to “Hold” rating and $42.0 target in Monday, October 23 report. The firm has “Sell” rating given on Friday, August 21 by Zacks. The rating was maintained by Robert W. Baird with “Hold” on Monday, December 4. The company was maintained on Monday, July 31 by Gabelli. The rating was upgraded by Zacks to “Hold” on Friday, September 4. The company was maintained on Wednesday, October 28 by Northland Capital. The firm earned “Outperform” rating on Wednesday, April 13 by Robert W. Baird.

Leave a Reply

Your email address will not be published. Required fields are marked *